APA (7th ed.) Citation

DC, K., JB, B., LL, N., X, G., CL, B., JH, H., . . . Maggs, D. G. (2008). Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Current Medical Research & Opinion, 24(1), 275. https://doi.org/10.1185/030079907x253870

Chicago Style (17th ed.) Citation

DC, Klonoff, et al. "Exenatide Effects on Diabetes, Obesity, Cardiovascular Risk Factors and Hepatic Biomarkers in Patients with Type 2 Diabetes Treated for at Least 3 Years." Current Medical Research & Opinion 24, no. 1 (2008): 275. https://doi.org/10.1185/030079907x253870.

MLA (9th ed.) Citation

DC, Klonoff, et al. "Exenatide Effects on Diabetes, Obesity, Cardiovascular Risk Factors and Hepatic Biomarkers in Patients with Type 2 Diabetes Treated for at Least 3 Years." Current Medical Research & Opinion, vol. 24, no. 1, 2008, p. 275, https://doi.org/10.1185/030079907x253870.